Figure 4
From: A hunter virus that targets both infected cells and HIV free virions: Implications for therapy
Effect of HIV turnover rate on therapy efficiency . Recovery decreases as HIV turnover rate increases. The decrease is steeper for a fusion-capable hunter, decreasing (but not eliminating) its advantage over fusion-incapable hunter at high turnover rates. Within this range, the fusion model displays periodic oscillations at lower HIV turnover rates (<1.7× default). Otherwise, the models reach a stable equilibrium.